Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-19-054789

Chief Financial Officer sold 37,884 shares at an average $40.85 ($1,547,378)

  • Chief Financial Officer acquired 37,884 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Myszkowski Kenneth Allen Chief Financial Officer 2019-11-01 Option exercise +37,884 $7.75 $293,601 351,420 D
Myszkowski Kenneth Allen Chief Financial Officer 2019-11-01 Sale −21,264 $40.56 $862,468 330,156 D
Myszkowski Kenneth Allen Chief Financial Officer 2019-11-01 Sale −16,620 $41.21 $684,910 313,536 D
Derivatives
Myszkowski Kenneth Allen Chief Financial Officer 2019-11-01 Option exercise · Stock Option (right to buy) −37,884 162,116 D
Open-market sales · 37,884 sh · avg $40.85 · $1,547,378
Loading xslF345X03/doc4.xml…